Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.

NCT05932732 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

27

Enrollment

NETWORK

Sponsor class

Conditions

Cutis Laxa Facialis
Xeroderma

Interventions

DEVICE: HydraFacial Syndeo System
DRUG: ReGen-GF
DEVICE: HydraFacial Elite MD System

Sponsor

Austin Institute for Clinical Research

Collaborators

[object Object]